Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Colorcon
McKinsey
Harvard Business School
Express Scripts

Last Updated: May 28, 2022

Merlion Pharms Gmbh Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MERLION PHARMS GMBH, and when can generic versions of MERLION PHARMS GMBH drugs launch?

MERLION PHARMS GMBH has one approved drug.

There are four US patents protecting MERLION PHARMS GMBH drugs.

There are forty-two patent family members on MERLION PHARMS GMBH drugs in eighteen countries.

Summary for Merlion Pharms Gmbh
International Patents:42
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Merlion Pharms Gmbh

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No 9,504,691 See Plans and Pricing Y See Plans and Pricing
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No 9,993,483 See Plans and Pricing Y See Plans and Pricing
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No 9,119,859 See Plans and Pricing See Plans and Pricing
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No 8,536,167 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Merlion Pharms Gmbh

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 6,133,260 See Plans and Pricing
Merlion Pharms Gmbh XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 6,432,948 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for Merlion Pharms Gmbh Drugs

Country Patent Number Estimated Expiration
European Patent Office 2448587 See Plans and Pricing
Japan 2015134827 See Plans and Pricing
China 109908081 See Plans and Pricing
Argentina 093813 See Plans and Pricing
Russian Federation 2570731 See Plans and Pricing
Canada 2888641 See Plans and Pricing
Japan 2012532115 See Plans and Pricing
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Dow
McKinsey
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.